The regional parliament once again discussed the situation with the provision of drugs to beneficiaries. At the moment there is a deficit, but the situation is being resolved. The participants of the working group found it to be “cautiously optimistic.
As of May 25 there were 336 prescriptions for federal beneficiaries on the deferred maintenance. A couple of months ago there were six times as many of them. There is not much optimism among regional beneficiaries, however. More than 2.3 thousand prescriptions remain unsubsidized. The Department of Health blames chief physicians of medical institutions for creating a shortage of subsidized drugs.
“In clinics they violate the rules on a mass scale and make prescriptions not by international generic names, but by trade names. It turns out that there are millions of dollars’ worth of purchased drugs in the warehouse, but people are not given them: often, there are analogs with the same active ingredient, but not the one specified in the prescription,” – the website of the Regional State Assembly reports.
Narrow prescribing of drugs is justified in some cases due to individual tolerance. In most cases, it is possible to choose a drug from a dozen analogues according to the active substance, said acting deputy governor Olga Grebneva.
“One third of the remainder are drugs outside the VED list (vital and essential medicines). We have them under other names, but patients are left without treatment. Plus excessive spending of budget money – prescriptions are already written, and we have to buy more drugs for them”.
An inspection by the Department of Health and Roszdravnadzor only confirmed that drugs are unreasonably prescribed by trade names without correlating them to their availability in stock.
Participants in the working group agreed that in the region, the executive staff at medical institutions had changed – they lacked experience. But there was no methodological assistance from the department. In addition, a lot of forms were cancelled last year, and the situation was left to chance. As a result, additional funds had to be allocated from the regional budget to remedy the situation. But money alone will not fix the situation.
“Pouring money on the problem indefinitely is impossible. “Frankly speaking, I have no idea what balances we will come up with by the end of the year. And we can’t know how many new beneficiaries will be identified,” Grebneva said.
Even now, the regional authorities need to prepare for next year’s procurement and prevent a repetition of mistakes. To do this, they will have to retrain personnel to formulate requests for drugs and monitor the procurement of drugs.
“Perhaps for the first time in all this time we have heard from representatives of the executive branch not only speeches about “who is to blame”, but also suggestions on “what to do”. It is necessary to restore, to build a vertical and a clear algorithm for prescribing discount drugs, to introduce an electronic system of online accounting and control of the entire system of preferential drug provision”, – said the head of the working group deputy Sergei Biryukov.
The working group also decided that until the situation is fully stabilized, the Regional Public Health Service will report to the deputies on the status of medicines at least twice a month.